69 related articles for article (PubMed ID: 21922643)
1. Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma.
Schmid I; Häberle B; Albert MH; Corbacioglu S; Fröhlich B; Graf N; Kammer B; Kontny U; Leuschner I; Scheel-Walter HG; Scheurlen W; Werner S; Wiesel T; von Schweinitz D
Pediatr Blood Cancer; 2012 Apr; 58(4):539-44. PubMed ID: 21922643
[TBL] [Abstract][Full Text] [Related]
2. Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib.
Vincenzi B; Santini D; Russo A; Addeo R; Giuliani F; Montella L; Rizzo S; Venditti O; Frezza AM; Caraglia M; Colucci G; Del Prete S; Tonini G
Oncologist; 2010; 15(1):85-92. PubMed ID: 20051477
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial combined immunochemotherapy for unresectable hepatocellular carcinoma: preliminary results.
Oka M; Hazama S; Yoshino S; Shimoda K; Suzuki M; Shimizu R; Yano K; Nishida M; Suzuki T
Cancer Immunol Immunother; 1994 Mar; 38(3):194-200. PubMed ID: 8124688
[TBL] [Abstract][Full Text] [Related]
4. Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report.
Cui K; Li Z; Zhong J; Shi X; Zhao L; Li H; Ma Y
Front Oncol; 2024; 14():1355798. PubMed ID: 38380371
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib-Induced Erythema Multiforme Major and Severe Hepatic Failure in Metastatic Hepatocellular Carcinoma: A Case Report.
Abrini H; Amzerin M; El Mrabet FZ
Cureus; 2024 Mar; 16(3):e57179. PubMed ID: 38681290
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies.
Murawski M; Weeda VB; Maibach R; Morland B; Roebuck DJ; Zimmerman A; Casanova M; Perilongo G; Laithier V; Kebudi R; Scopinaro MJ; Shun A; Brichard B; de Camargo B; Childs M; Aronson DC; Czauderna P
J Clin Oncol; 2016 Apr; 34(10):1050-6. PubMed ID: 26811523
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective.
Pearson H; Marshall LV; Carceller F
Pediatr Hematol Oncol; 2020 Aug; 37(5):412-423. PubMed ID: 32183592
[TBL] [Abstract][Full Text] [Related]
8. Pediatric hepatocellular carcinoma: challenges and solutions.
Schmid I; von Schweinitz D
J Hepatocell Carcinoma; 2017; 4():15-21. PubMed ID: 28144610
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunophenotype correlating with response to immunotherapy in paediatric patients with primary liver carcinoma. A case series.
O'Neill AF; Church AJ; Feraco A; Spidle J; Wall CB; Kim HB; Elisofon S; Vakili K; Pimkin M; Dharia NV; Shelman NR; Perez-Atayde AR; Rodriguez-Galindo C
EBioMedicine; 2024 May; 104():105147. PubMed ID: 38749302
[TBL] [Abstract][Full Text] [Related]
10. An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer.
Espinoza AF; Kureti P; Patel RH; Do SL; Govindu SR; Armbruster BW; Urbicain M; Patel KR; Lopez-Terrada D; Vasudevan SA; Woodfield SE
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727682
[TBL] [Abstract][Full Text] [Related]
11. Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part I.
Dong Y; Cekuolis A; Schreiber-Dietrich D; Augustiniene R; Schwarz S; Möller K; Nourkami-Tutdibi N; Chen S; Cao JY; Huang YL; Wang Y; Taut H; Grevelding L; Dietrich CF
Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066809
[TBL] [Abstract][Full Text] [Related]
12. Children's Oncology Group's 2023 blueprint for research: Liver tumors.
O'Neill AF; Meyers RL; Katzenstein HM; Geller JI; Tiao GM; López-Terrada D; Malogolowkin M;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30576. PubMed ID: 37495540
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin in Liver Cancer Therapy.
Hamaya S; Oura K; Morishita A; Masaki T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446035
[TBL] [Abstract][Full Text] [Related]
14. Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis.
Spini A; Ciccone V; Rosellini P; Ziche M; Lucenteforte E; Salvo F; Donnini S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358734
[TBL] [Abstract][Full Text] [Related]
15. Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
Short SS; Kastenberg ZJ; Wei G; Bondoc A; Dasgupta R; Tiao GM; Watters E; Heaton TE; Lotakis D; La Quaglia MP; Murphy AJ; Davidoff AM; Mansfield SA; Langham MR; Lautz TB; Superina RA; Ott KC; Malek MM; Morgan KM; Kim ES; Zamora A; Lascano D; Roach J; Murphy JT; Rothstein DH; Vasudevan SA; Whitlock R; Lal DR; Hallis B; Bütter A; Baertschiger RM; Lapidus-Krol E; Putra J; Tracy ER; Aldrink JH; Apfeld J; Le HD; Park KY; Rich BS; Glick RD; Fialkowski EA; Utria AF; Meyers RL; Riehle KJ
Cancer; 2022 Jul; 128(14):2786-2795. PubMed ID: 35561331
[TBL] [Abstract][Full Text] [Related]
16. International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.
de Campos Vieira Abib S; Chui CH; Cox S; Abdelhafeez AH; Fernandez-Pineda I; Elgendy A; Karpelowsky J; Lobos P; Wijnen M; Fuchs J; Hayes A; Gerstle JT
Ecancermedicalscience; 2022; 16():1356. PubMed ID: 35510137
[TBL] [Abstract][Full Text] [Related]
17. Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review.
Kakos CD; Ziogas IA; Demiri CD; Esagian SM; Economopoulos KP; Moris D; Tsoulfas G; Alexopoulos SP
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267604
[TBL] [Abstract][Full Text] [Related]
18. 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.
Kumar A; Acharya SK; Singh SP; Arora A; Dhiman RK; Aggarwal R; Anand AC; Bhangui P; Chawla YK; Datta Gupta S; Dixit VK; Duseja A; Kalra N; Kar P; Kulkarni SS; Kumar R; Kumar M; Madhavan R; Mohan Prasad VG; Mukund A; Nagral A; Panda D; Paul SB; Rao PN; Rela M; Sahu MK; Saraswat VA; Shah SR; Shalimar ; Sharma P; Taneja S; Wadhawan M;
J Clin Exp Hepatol; 2020; 10(1):43-80. PubMed ID: 32025166
[TBL] [Abstract][Full Text] [Related]
19. Rare malignant liver tumors in children.
Chavhan GB; Siddiqui I; Ingley KM; Gupta AA
Pediatr Radiol; 2019 Oct; 49(11):1404-1421. PubMed ID: 31620842
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma.
Marin JJG; Cives-Losada C; Asensio M; Lozano E; Briz O; Macias RIR
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30909445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
